Rankings
▼
Calendar
CYTK FY 2025 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena
CYTK
Cytokinetics, Incorporated
$8B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$88M
+376.6% YoY
Gross Profit
$78M
88.5% margin
Operating Income
-$612M
-695.4% margin
Net Income
-$785M
-891.6% margin
EPS (Diluted)
$-6.54
Cash Flow
Operating Cash Flow
-$510M
Free Cash Flow
-$535M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$2.1B
Stockholders' Equity
-$660M
Cash & Equivalents
$882M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$88M
$18M
+376.6%
Gross Profit
$78M
-$321M
+124.3%
Operating Income
-$612M
-$536M
-14.2%
Net Income
-$785M
-$590M
-33.2%
← Q4 2024
All Quarters
Q1 2025 →